Early Adherence to Immunomodulators in Multiple Myeloma: Retrospective Observations from a Safety-Net Hospital.
Simple Summary: Multiple myeloma is a blood cancer that disproportionately affects racial and ethnic minorities and people with limited financial resources. Immunomodulators, a key drug class for this cancer, work best when taken consistently and started promptly after diagnosis. This study examined...
| Publicado en: | Current Oncology Vol. 33; no. 7; pp. 432 - 444 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jul2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |